Onesource Specialty Pharma Lim (ONESOURCE)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 67.98 392.56 425.95 327.27 375.76 290.34 428.22
YOY Revenue Growth % - - - - 452.76% -26.04% 0.53%
Other Income 0.58 5.39 2.89 5.27 3.04 4.63 2.09
Total Income 68.56 397.96 428.84 332.54 378.80 294.97 430.31
Total Expenses + 67.86 240.68 345.34 334.07 373.06 380.89 430.64
Cost of Materials Consumed 12.31 92.86 90.99 83.36 123.55 87.73 144.51
Employee Benefit Expense 22.78 57.35 51.06 58.44 62.82 64.19 62.74
Other Expenses 32.77 90.47 81.47 87.43 92.96 114.46 127.29
Operating Profit 0.12 151.89 80.61 -6.80 2.71 -90.55 -2.42
OPM % 0.2% 38.7% 18.9% -2.1% 0.7% -31.2% -0.6%
Profit Before Tax + -39.08 -66.50 83.50 -4.40 5.74 -93.01 -0.29
Tax Expense 0.24 2.35 -14.70 -4.21 -4.74 -4.31 -4.89
Tax % - - -17.6% - -82.6% - -
Profit After Tax -39.33 -68.85 98.20 -0.19 10.49 -88.70 4.60
EPS (Basic) -18.82 -6.31 8.61 -0.02 0.92 -7.74 0.40

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025
Revenue from Operations 1,444.85
YOY Revenue Growth % -
Other Income 17.47
Total Income 1,462.33
Total Expenses + 1,418.55
Cost of Materials Consumed 328.24
Employee Benefit Expense 215.26
Other Expenses 328.05
Operating Profit 26.31
OPM % 1.8%
Profit Before Exceptional 43.78
Exceptional Items -110.85
Profit Before Tax + -67.07
Tax Expense -49.10
Tax % -
Profit After Tax -17.97
EPS (Basic) -1.63

Balance Sheet

Particulars Mar 2025
ASSETS
Non-Current Assets + 6,464.06
Property, Plant & Equipment 897.35
Capital Work in Progress 60.37
Non-Current Investments 6.91
Goodwill 3,827.53
Other Intangible Assets 1,392.64
Current Assets + 1,086.18
Inventories 158.06
Trade Receivables 416.60
Cash and Cash Equivalents 156.48
Current Investments 8.88
LIABILITIES & EQUITY
Total Equity 0.00
Equity Share Capital 11.44
Other Equity 5,869.14
Non-Current Liabilities 556.10
Current Liabilities 1,113.56
Total Liabilities 1,669.66

Cash Flow Statement

Particulars Mar 2025
Cash from Operating Activities -21.52
Cash from Investing Activities -201.08
Cash from Financing Activities 1,987.17
Net Increase/Decrease in Cash 1,764.58